Clinical Trial Update: A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice

View source ↗

Summary

This completed clinical trial studied how the duration of treatment relates to patient response in real-world cases of multiple myeloma or light-chain (AL) amyl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Light-chain Amyloidosis
• Multiple Myeloma

Snippet

Sponsor: Takeda | Conditions: Multiple Myeloma, Immunoglobulin Light-chain Amyloidosis | Status: COMPLETED